Abstract
Normally, contractions of smooth muscle, which follow activation of the ATPase properties of myosin by phosphorylation in the presence of calmodulin and Ca (Chapter 2), are terminated by withdrawal of the initiating stimulus followed by a fall in the free cytoplasmic Ca concentration, mediated by the physiological systems that usually maintain the cation at a low level. Relaxation (or inhibition of contraction) in the presence of a contractile stimulus, can be achieved by a reduction in free cytoplasmic Ca levels or by reducing the rate of myosin phosphorylation in the presence of Ca-calmodulin through phosphorylation of myosin light chain kinase by a cyclic AMP-dependent phosphokinase (Chapter 2).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aiken, J. W. Inhibitors of prostaglandin synthesis specifically antagonize bradykinin and angiotensin-induced relaxations of the isolated celiac artery from the rabbit. Pharmacologist 16: 295, 1974.
Alexander, R. W., J. A. Fontana, and W. Lovenberg. cAMP dependent protein kinase in rabbit aortic microsomes and its relation to Ca’ uptake. Federation Proc. 32: 711, 1973.
Allen, C. J. Ca-binding properties of canine aortic microsomes: lack of effect of c-AMP. Blood Vessels 14: 91–104, 1977.
Asano, M., Y. Suzyki, and H. Hidaka. Effects of various calmodulin antagonists on contraction of rabbit aortic strips. J. Pharmacol. Exp. Ther. 220: 191–196, 1982.
Aurbach, G. D. Polypeptide and amine hormone regulation of adenylate cyclase. Ann. Rev. Physiol. 44: 653–666, 1982.
Berridge, M. J. Receptors and calcium signalling. TIPS 1: 419–424, 1980.
Bhalla, R. C., R. C. Webb, D. Singh, and T. Brock. Role of cyclic AMP in aortic microsomal phosphorylation and calcium uptake. Am. J. Physiol. 234:HSO8–H514, 1978.
Bohme, E., H. Graf, and G. Schultz. Effects of sodium nitroprusside and other smooth muscle-relaxants on cyclic GMP formation in smooth muscle and platelets. Adv. Cyclic Nucleotide Res. 9: 131–143, 1978.
Bolton, T. B. Mechanisms of action of transmitters and other substances on smooth muscle. Physiol. Rev. 59: 606–718, 1979.
Boström, S. L., B. Ljung, S. Mardh, S. Forsen, and E. Thulin. Interaction of the antihypertensive drug felodipine with calmodulin. Nature 292: 777–778, 1981.
Broekaert, A., and T. Godraind. A comparison of the inhibition by cinnarizine and papaverine of the noradrenaline evoked contraction of isolated rabbit vessels in presence and absence of extracellular calcium. Eur. J. Pharmacol. 53: 281–288, 1979.
Bucher, B., C. Heitz, and J. C. Stoclet. In vivo decrease of adenylate cyclase responsiveness to isoproterenol in the spontaneously hypertensive rat. Biochem. Pharmacol. 30: 2583–2506, 1981.
Cauvin, C., R. Loutzenhiser, and C. van Breemen. Mechanisms of calcium antagonist-induced vasodilation. Ann. Rev. Pharmacol. Toxicol 23: 373–396, 1983.
Cherry, P. D., R. F. Furchgott, and J. V. Zawadzki. The indirect nature of bradykinin relaxation of isolated arteries: endothelial dependent and independent components. Federation Proc. 40: 689, 1980.
Cherry, P. D., R. F. Furchgott, J. V. Zawadzki, and D. Jothianandan. Role of endothelial cells in relaxation of isolated arteries by bradykinin. Proc. Natl. Acad. Sci. 79: 2106–2110, 1982.
Clyman, R. I., V. C. Manganiello, C. J. Lovell-Smith, and M. Vaughan. Calcium uptake by subcellular fractions of human umbilical artery. Am. J. Physiol. 231: 1074–1081, 1976.
Cornish, E. J., R. G. Goldie, E. V. Krstew, and R. C. Miller. Effect of indomethacin on responses of sheep isolated coronary artery to arachidonic acid. Clin. Exp. Pharmacol. Physiol. 10: 171–175, 1983.
Cornish, E. J., Goldie, and R. C. Miller. Catecholamine uptake by isolated coronary arteries and atria of the kitten. Br. J. Pharmacol. 63: 445 456, 1978.
De Mey, J. G., and P. M. Vanhoutte. Role of the intima in cholinergic and purinergic relaxation of isolated canine femoral arteries. J. Physiol., London 316: 347–355, 1981.
Diamond, J. Evidence for dissociation between cyclic nucleotide levels and tension in smooth muscle. In: The Biochemistry of Smooth Muscle, edited by N. L. Stephens. Baltimore: University Park Press, pp 343–360, 1977.
Diamond, J. Role of cyclic nucleotides in control of smooth muscle contraction. In: Advances in Cyclic Nucleotide Research, edited by W. G. George and L. J. Ignarro: New York: Raven Press, Vol 9, p 327, 1978.
Duckles, S. P., and S. I. Said. Vasoactive intestinal peptide as a neurotransmitter in the cerebral circulation. Eur. J. Pharmacol. 78: 371–374, 1982.
Ericsson, E. E. Adrenergic beta-receptor activity and cyclic AMP-metabolism in vascular smooth muscle, variations with age. Scand. J. Clin. Lab. Invest. 34:Suppl 141, 63, 1974.
Filburn, C. R., F. T. Colpo, and B. Sacktor. Mechanism of phenothiazine inhibition of Cat+-dependent guanosine (cyclic) monophosphate phosphodiesterase of brain. Mol. Pharmacol. 15: 257–262, 1979.
Fitzpatrick, D. F., and A. Szentivanyi. Stimulation of calcium uptake into aortic microsomes by cyclic AMP and cyclic AMP dependent protein kinase. Naunyn-Schmiedeberg’s Arch. Pharmacol. 298: 255–257, 1977.
Fleckenstein, A. Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Ann. Rev. Pharmacol. Toxicol. 17: 149–166, 1977.
Fleisch, J. H. Further studies on the effect of aging on betaadrenoceptor activity of rat aorta. Br. J. Pharmacol. 42: 311–313, 1971.
Fleisch, J. H. Age-related changes in the sensitivity of blood vessels to drugs. Pharmacol, Ther. 8: 477–487, 1980.
Flower, R. J. Drugs which inhibit prostaglandin biosynthesis, Pharmacol. Rev. 26: 33–67, 1974.
Flower, R. J. and C. J. Blackwell. The importance of phospholipase-A2 in prostaglandin biosynthesis. Biochem. Pharmacol. 25: 285–291, 1976.
Furchgott, R. F., and J. V. Zawadzki. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373–376, 1980.
Furchgott, R. F., and J. V. Zawadzki. ATP relaxes rabbit aortic smooth muscle by both an indirect action via endothelial cells and a direct action. Pharmacologist 22: 271, 1980.
Godfraind, T. The action of cinnarizine and of phentolamine on the noradrenaline-depressant calcium influx in vascular smooth muscle. Br. J. Pharmacol. 52: 120P, 1974.
Godfraind, T. Isoprenaline relaxation in vascular smooth muscle of aged rats: effect of flunarizine. Arch. int. Pharmacodyn. Ther. 230: 331, 1977.
Godfraind, T. Alternative mechanisms for the potentiation of the relaxation evoked by isoprenaline in aortae from young and aged rats. Eur. J. Pharmacol. 53: 273–279, 1979.
Godfraind, T. Mechanism of action of calcium entry blockers. Federation Proc. 40: 2866–2871, 1982.
Godfraind, T. Actions of nifedipine on Ca fluxes and contraction in isolated arteries. J. Pharmacol. Exp. Ther. 224: 443–450, 1983.
Godfraind, T., and D. Dieu. The inhibition by flunarizine of the norepinephrine-evoked contraction and calcium influx in rat aorta and mesenteric arteries. J. Pharmacol. Exp. Ther. 217: 510–515, 1981.
Godfraind, T., and A. Kaba. Blockade or reversal of the contraction induced by calcium and adrenaline in depolarized arterial smooth muscle. Br. J. Pharmacol. 36: 549–560, 1969.
Godfraind, T., A. Kaba, and P. Polster. Differences in sensitivity of arterial smooth muscles to inhibition of their contractile response to depolarization by potassium. Arch. int. Pharmacodyn. Ther. 172: 235–239, 1968.
Godfraind, T., and R. C. Miller. Actions of PGF2,, and noradrenaline on Ca exchange and contraction in rat mesenteric arteries and their sensitivity to calcium entry blockers. Br. J. Pharmacol. 75: 229–236, 1982.
Godfraind, T., and R. C. Miller. The study of receptors and Ca movements in smooth muscle as a model for presynaptic events. In: Neurotransmitter Interactions and Compartmentation, edited by H. F. Bradford: New York, London: pp 121–139, 1982.
Godfraind, T., and R. C. Miller. Specificity of action of Ca entry blockers, a comparison of their actions in rat arteries and in human coronary arteries. Circulation Res. 52:Suppl. 1, 181–191, 1983.
Godfraind, T., and R. C. Miller. Pharmacology of coronary arteries. In: Factors Influencing the Course of Myocardial Ischemia, edited by Gotto and DeBakey: Amsterdam-New York-Oxford, Elsevier Biomedical Press, pp 101–119, 1983.
Godfraind, T., R. C. Miller, and J. Socrates Lima. Selective alphaland alpha2-adrenoceptor agonist-induced contractions and 45Ca fluxes in the rat isolated aorta. Br. J. Pharmacol. 77: 597–604, 1982.
Godfraind, T., and N. Morel. Identification of the specific binding of flunarizine to rat aorta. Br. J. Pharmacol. 75: 517P, 1981.
Godfraind, T., and P. Polster. Etude comparative de médicaments inhibant la réponse contractile de vaisseaux isolés d’origine humaine ou animale. Thérapie 23: 1209–1220, 1968.
Goldberg, N. D., and M. K. Haddox. Cyclic GMP metabolism and involvement in biological regulation. Ann. Rev. Biochem. 46: 823–896, 1977.
Greengard, P. Cyclic nucleotides, phosphorylated proteins and neuronal function. Distinguished lecture series of the Society of General Physiologists, Vol 1, New York: Raven Press, 1978.
Hardman, J. G. Cyclic nucleotides and smooth muscle contractions: some conceptual and experimental considerations. In: Smooth Muscle, edited by E. Bulbring, A. F. Brading, A. W. Jones, and T. Tomita. London: Edward Arnold, pp 249–262, 1981.
Hayashi, S., and N. Toda. Age related changes in the response of rabbit isolated aortae to vasoactive agents. Br. J. Pharmacol. 64: 229–237, 1978.
Hidaka, H., T. Yamaki, M. Naka, T. Tanaka, H. Hayashi, and R. Kobayashi. Calcium-regulated modulator protein interacting agents inhibit smooth muscle calcium-stimulated protein kinase and ATPase. Mol. Pharmac. 17: 66–72, 1980.
Hidaka, H., T. Yamaki, T. Totsuka, and M. Asano. Selective inhibitors of Cat `-binding modulators of phosphodiesterase produce vascular relaxation and inhibit actinomyosin interaction. Mol. Pharmacol. 15: 49–59, 1979.
Krebs, E. G., and J. A. Beavo. Phosphorylation-dephosphorylation of enzymes. Ann. Rev. Biochem. 48: 923–959, 1979.
Kukovetz, W. R., A. Wurm, I. Rinner, S. Holzmann, and G. Poch. Stimulation of adenylcyclase in coronary smooth muscle by adenosine. In: Excitation-contraction Coupling in Smooth Muscle, edited by R. Casteels, T. Godfraind, and J. C. Rüegg. Amsterdam: Elseviar Biomedical Press, pp 399–406, 1977.
Kulkarni, P. S., R. Roberts, and P. Needleman. Endogenous synthesis of a labile coronary dilating substance from arachidonic acid. Federation Proc. 35: 298, 1976.
Kulkarni, P. S., R. Roberts, and P. Needleman. Paradoxical endogenous synthesis of a coronary dilating substance from arachidonate. Prostaglandins 12: 337–353, 1976.
Levin, R. M., and B. Weiss. Binding of trifluoperazine to the calcium-dependent activator of cyclic nucleotide phosphodiesterase. Mol. Pharmacol. 13: 690–697, 1977.
Levin, R. M., and B. Weiss. Selective binding of antipsychotics and other psychoactive agents to the calcium-dependent activator of cyclic nucleotide phosphodiesterase. J. Pharmacol. Exp. Ther. 208: 454–459, 1979.
Maclntyre, D. E., J. D. Pearson, and J. L. Gordon. Localization and stimulation of prostacyclin production in vascular cells. Nature 271: 549–551, 1978.
Meisheri, K. D., and C. van Breemen. Effects of beta-adrenergic stimulation on calcium movements in rabbit aortic smooth muscle: relationship with cyclic AMP. J. Physiol. London 331: 429–441, 1982.
Moncada, S., A. G. Herman, E. A. Higgs, and J. R. Vane. Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium. Thromb. Res. 11: 323–344, 1977.
Moncada, S., and J. R. Vane. Arachidonic acid metabolites in the cardiovascular system. In: Cell Membrane in Function and Dysfunction of Vascular Tissue, edited by T. Godfraind, and P. Meyer. Holland: Elsevier Biomedical Press, pp 105–126, 1981.
Morel, N., M. Wibo, and T. Godfraind. A calmodulin-stimulated Cat+ pump in rat aorta plasma membranes. Biochim. Biophys. Acta 644: 82–88, 1981.
Murad, F., C. K. Mittal, W. P. Arnold, and J. M. Braughler. Effect of nitrocompound smooth muscle relaxants and other materials on cyclic GMP metabolism. In: Advances in Pharmacology and Therapeutics, Vol 3, Ions-Cyclic Nucleotides-Cholinergy, edited by J. C. Stoclet. Oxford: Pergamon Press, pp 125–132, 1978.
Murphy, E., K. Coll, T. L. Rich, and J. R. Williams. Hormonal effects on calcium homeostasis in isolated hepatocytes. J. Biol. Chem. 255: 6600–6608, 1980.
Nimmo, H. G., and P. Cohen. Hormonal control of protein phosphorylation. Adv. Cyclic Nucleotide Res. 8: 145–266, 1977.
Nishikori, K., T. Takenaka, and H. Maeno. Stimulation of microsomal calcium uptake and protein phosphorylation by adenosine cyclic 3’, 5’-monophosphate in rat uterus. Mol. Pharmacol. 13: 671–678, 1977.
Norman, J. A., A. H. Drummond, and P. Moser. Inhibition of calcium-dependent regulator-stimulated phosphodiesterase activity by neuroleptic drugs is unrelated to their clinical efficacy. Mol. Pharmacol 16: 1089–1094, 1979.
Popescu, L. M. Cytochemical study of the intracellular calcium distribution in smooth muscle. In: Excitation-Contraction Coupling in Smooth Muscle, edited by R. Casteels, T. Godfraind, and J. C. Rüegg. Holland: Elsevier Biomedical Press, pp 13–23, 1977.
Rapoport, R. M., M. B. Draznin, and F. Murad. Sodium nitroprusside-induced protein phosphorylation in intact rat aorta is mimicked by 8-bromo cyclic GMP. Proc. Natl. Acad. Sci. 79: 6470–6474, 1982.
Rodbell, M. The role of hormone receptors and GTP-regulatory proteins in membrane transduction. Nature 284: 17–22, 1980.
Saida, K., and C. van Breemen. Mechanisms of Ca’ antagonist-induced vasodilation. Intracellular actions. Circulation Res. 52: 137–142, 1983.
Salmon, J. A., D. R. Smith, R. J. Flower, S. Moncada, and J. R. Vane. Further studies on the conversion of prostaglandin endoperoxide into prostacyclin by porcine aorta microsomes. Biochim. biophys. Acta 523: 250–262, 1978.
Sands, H., J. Mascali, and E. Paietta. Determination of calcium transport and phosphoprotein phosphatase activity in microsomes from respiratory and vascular smooth muscle. Biochim. Biophys. Acta 500: 223–234, 1977.
Schoeffter, P., and J. C. Stoclet. Age-related decrease of in vitro isoproterenol-induced cyclic AMP accumulation in rat aorta. Eur. J. Pharmacol. 77: 183–186, 1982.
Schultz, G., and J. G. Hardman. Regulation of cyclic GMP levels in the ductus deferens of the rat. Adv. Cyclic. Nucleotide Res. 5: 339–351, 1975.
Silberbauer, K., H. Sinzinger, M. Winter, W. Fiegl, and F. Ring. Prostacyclin-like activity of endothelium and subendotheliumimportant for atherosclerosis? Experientia 34: 1471–1472, 1978.
Spedding, M. Comparison of “Ca’-antagonists” and trifluoperazine in skinned smooth muscle fibres. Br. J. Pharmacol. 75: 25P, 1982.
Starke, K. Regulation of noradrenaline release by presynaptic receptor systems. Rev. Physiol. Biochem. Pharmacol. 77: 1–124, 1977.
Stoclet, J. C., and C. Lugnier. Inhibitors of cyclic nucleotide phosphodiesterases. In: Medicinal Chemistry Advances, edited by F. G. De Las Heras, and S. Vega. Oxford and New York: Pergamon Press, pp 435–445, 1981.
Taylor, W. M., V. Prpie, J. H. Exton, and F. L. Bygrave. Stable changes to calcium fluxes in mitochondria isolated from rat livers per-fused with alpha-adrenergic agonists and with glucagon. Biochem. J. 188: 443–450, 1980.
Terragno, D. A., K. Crowshaw, N. A. Terragno, and J. C. McGiff. Prostaglandin synthesis by bovine mesenteric arteries and veins. Circulation Res. 36 (Suppl.1), 176–180, 1975.
Toda, N., and S. Hayashi. Age-dependent alteration in the response of isolated rabbit basilar arteries to vasoactive agents. J. Pharmacol. Exp. Ther. 211: 716–721, 1979.
van Breemen, C., O. Hwang, and K. D. Meisheri. The mechanism of inhibitory action of diltiazem on vascular smooth muscle contractility. J. Pharmacol. Exp. Ther. 218: 459–463, 1981.
Vane, J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 231: 232–235, 1971.
Van Nueten, J. M. Selectivity of calcium entry blockers. In: Calcium Modulators, edited by T. Godfraind, A. Albertini, and R. Paoletti. Holland: Elsevier Biomedical Press, pp 199–208, 1982.
Weiss, G. B. Sites sensitive to different types of calcium antagonist. In: Calcium Modulators, edited by T. Godfraind, A. Albertini, and R. Paoletti. Holland: Elsevier Biomedical Press, pp 209–220, 1982.
Weksler, B. B., A. J. Marcus, and E. A. Jaffe. Synthesis of prostaglandin 12 (prostacyclin) by cultured human and bovine endothelial cells. Proc. Natl. Acad. Sci. 74: 3922–3926, 1977.
Wells, J., N., and J. G. Hardman. Cyclic nucleotide phosphodiesterases. Adv. Cyclic Nucleotide Res. 8: 119–143, 1977.
Wibo, M., N. Morel, and T. Godfraind. Differentiation of Cat+ pumps linked to plasma membrane and endoplasmic reticulum in the microsomal fraction from intestinal smooth muscle. Biochim. Biophys. Acta 649: 651–660, 1981.
Zawadzki, J. V., P. B. Cherry, and R. F. Furchgott. Comparison of endothelial-dependent relaxation of rabbit aorta by A23187 and by acetylcholine. Pharmacologist 22: 271, 1980.
Zawadzki, J. V., R. F. Furchgott, and P. Cherry. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by substance P. Federation Proc. 40: 689, 1981.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 The Humana Press Inc.
About this chapter
Cite this chapter
Godfraind, T., Miller, R.C. (1985). Mechanisms of Smooth Muscle Relaxation. In: Grover, A.K., Daniel, E.E. (eds) Calcium and Contractility. Contemporary Biomedicine, vol 5. Humana Press. https://doi.org/10.1007/978-1-4612-5172-9_4
Download citation
DOI: https://doi.org/10.1007/978-1-4612-5172-9_4
Publisher Name: Humana Press
Print ISBN: 978-1-4612-9596-9
Online ISBN: 978-1-4612-5172-9
eBook Packages: Springer Book Archive